Overview

Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Double-masked, randomized, multi-center, dose-response, active-controlled parallel-comparison of AR-13324 to latanoprost
Phase:
Phase 2
Details
Lead Sponsor:
Aerie Pharmaceuticals
Treatments:
Antihypertensive Agents
Latanoprost
Ophthalmic Solutions
Pharmaceutical Solutions